⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JUNS News
Jupiter Neurosciences, Inc. Common Stock
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
globenewswire.com
JUNS
DYAI
PHIO
CVKD
TNXP
MTVA
XAIR
AEMD
NSRX
ICU
JAGX
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
globenewswire.com
JUNS
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
globenewswire.com
JUNS
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026
globenewswire.com
JUNS
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026
globenewswire.com
JUNS
Form 8-K
sec.gov
JUNS
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago
globenewswire.com
JUNS
Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)
globenewswire.com
JUNS
BMBL
NVO
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution
globenewswire.com
JUNS
Form 8-K
sec.gov
JUNS